Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20121021011192N18Phase 3Completed
Phase 3 trial of melatonin and zinc in Cirrhosis and sleep disorder (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Optimization of sleep disorder. Started Aug 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20121021011192N18.